🇺🇸 FDA
Patent

US 7404954

Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 7404954 (Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor) held by The Regents of the University of California expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P11/00